Venous thromboembolism (VTE) prophylaxis after spine surgery has long lived in the gray zone between “standard of care” and “please don’t sue me.” ...

ABSTRACT: This article reviews the current knowledge on venous thromboembolism (VTE) in patients with colorectal cancer during the perioperative period, systematically explores the risk factors ...

Learn the critical factors in determining prophylaxis for venous thromboembolism, a frequent and serious complication for patients with cancer. Several factors play a role in deciding whether a ...

Objective: Venous thromboembolism (VTE) presents a significant challenge for neurocritically ill patients with cancer due to the combined risks of thrombosis and bleeding. This study aimed to describe ...

The earliest published study on this topic was a retrospective case–control study by Northup and associates [8] focusing on 113 inpatients with cirrhosis who had newly diagnosed VTE during hospital ...

Lupin has received the Food and Drug Administration’s green light for rivaroxaban tablets, in 10 mg, 15 mg and 20 mg, which is the generic of Janssen’s Xarelto. This product will be manufactured at ...

ORLANDO -- Longer hospitalization for flares of inflammatory bowel disease (IBD) was linked to greater risk of subsequent venous thromboembolism (VTE) independent of other risk factors, according to a ...

The percentage of patients overall who triggered a CDS alert was significantly higher in the post-intervention period at 44.3%, compared with a rate of 8.9% in the pre-intervention period. The use of ...

There are multiple risk assessment models (RAMs) for venous thromboembolism prophylaxis, but it is unknown whether they increase appropriate prophylaxis. To determine the impact of a RAM embedded in ...